Back to Search Start Over

Partial restoration of GH responsiveness to ghrelin in Cushing's disease after 6 months of ketoconazole treatment: comparison with GHRP-6 and GHRH

Authors :
Ana-Maria J. Lengyel
Larissa Bianca Paiva Cunha de Sá
José Gilberto H. Vieira
Sergio Oliva Nascif
Silvia R. Correa-Silva
Patrícia Molica
Universidade Federal de São Paulo (UNIFESP)
Inst Fleury
Source :
Repositório Institucional da UNIFESP, Universidade Federal de São Paulo (UNIFESP), instacron:UNIFESP
Publication Year :
2009
Publisher :
Oxford University Press (OUP), 2009.

Abstract

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Objective: in Cushing's disease (CD), GH responsiveness to several stimuli, including ghrelin, GHRP-6, and GHRH. is blunted. Recovery of GH secretion after remission of hypercortisolism after transsphenoidal surgery. radiotherapy or adrenalectomy is controversial. There are no studies evaluating the effect of primary clinical treatment with ketoconazole on GH secretion in CD. the aim of this study is to compare ghrelin-, GHRP-6-, and GHRH-induced GH release before and after ketoconazole in MDesign: GH responses to ghrelin. GHRP-6, and GHRH of eight untreated patients with CD (mean age: 33.8 +/- 3.1 years; body mass index: 28.5 +/- 0.8 kg/m(2)) were evaluated before and after 3 and 6 months of ketoconazole treatment. and compared with I I controls (32.1 +/-.2.5: 25.0 +/- 0.8).Methods: Serum GH was measured by an immunofluorometric assay and urinary free cortisol (UFC) by liquid chromatography and tandem mass spectrometry.Results: After ketoconazole use, mean UFC decreased significantly (before: 222.4 +/- 35.0 mu g/24 h: third month: 61.6 +/-+10.1: sixth month: 39.1 +/- 10.9). Ghrelin-induced GH secretion increased significantly after 6 months (peak before: 6.8 +/- 2.3 mu g/l: sixth month: 16.0 +/- 3.6). but remained lower than that of controls (54.1 +/- 11.2). GH release after GHRP-6 increased, although not significantly. while GH responsiveness to GHRH Was unchanged.Conclusions: Ghrelin-induced GH release increases significantly after 6 months of ketoconazole treatment in CD. This could suggest that, it decrease in cortisol levels during this time period can partially restore glucocorticoid-induced GH suppression in CD. GH-releasing mechanisms stimulated by ghrelin/GHS could be more sensitive, as no changes in GHRH-induced GH release were observed. Universidade Federal de São Paulo, Div Endocrinol, BR-04039002 São Paulo, Brazil Inst Fleury, BR-04344903 São Paulo, Brazil Universidade Federal de São Paulo, Div Endocrinol, BR-04039002 São Paulo, Brazil FAPESP: 02/14118-9 Web of Science

Details

ISSN :
1479683X and 08044643
Volume :
161
Database :
OpenAIRE
Journal :
European Journal of Endocrinology
Accession number :
edsair.doi.dedup.....b65d1bb592befa3f635b30d11165d0b8
Full Text :
https://doi.org/10.1530/eje-09-0459